57.120 Surgical Site Infection (SSI)

The National Healthcare Safety Network (NHSN)

57.120_SSI_BLANK

57.120 Surgical Site Infection (SSI)

OMB: 0920-0666

Document [docx]
Download: docx | pdf


OMB No. 0920-0666

Exp. Date: xx-xx-xxxx

www.cdc.gov/nhsn

Surgical Site Infection (SSI)

Page 1 of 4

*required for saving **required for completion

Facility ID:

Event #:

*Patient ID:

Social Security #:

Secondary ID:

Medicare #:

Patient Name, Last:

First:

Middle:

*Gender: F M Other

*Date of Birth:

Ethnicity (Specify):

Race (Specify):

*Event Type: SSI

*Date of Event:

*NHSN Procedure Code:

ICD-9-CM Procedure Code:

*Date of Procedure:

*Outpatient Procedure: Yes No

*MDRO Infection Surveillance:

Yes, this infection’s pathogen & location are in-plan for Infection Surveillance in the MDRO/CDI Module

No, this infection’s pathogen & location are not in-plan for Infection Surveillance in the MDRO/CDI Module

*Date Admitted to Facility

Location

Event Details

*Specific Event:

Superficial Incisional Primary (SIP)

Deep Incisional Primary (DIP)

Superficial Incisional Secondary (SIS)

Deep Incisional Secondary (DIS)

Organ/Space (specify site): _______________________


*Specify Criteria Used (check all that apply):


Signs & Symptoms

Laboratory

Purulent drainage or material

Positive culture

Pain or tenderness

Not cultured

Localized swelling

Positive blood culture

Redness

Blood culture not done or no organisms detected in blood

Heat

Fever

Positive Gram stain when culture is negative or not done

Incision deliberately opened by surgeon

Wound spontaneously dehisces

Other positive laboratory tests

Abscess

Radiographic evidence of infection

Hypothermia


Apnea


Bradycardia

Clinical Diagnosis

Lethargy

Physician diagnosis of this event type

Cough

Physician institutes appropriate antimicrobial therapy

Nausea


Vomiting


Dysuria


Other evidence of infection found on direct exam, during surgery, or by diagnostic tests

per organ/space specific site criteria

Other signs & symptoms


*Detected:

A (During admission)

P (Post-discharge surveillance)

RF (Readmission to facility where procedure performed)

RO (Readmission to facility other than where procedure was performed)

*Secondary Bloodstream Infection: Yes No

**Died: Yes No

SSI Contributed to Death: Yes No

Discharge Date:

*Pathogens Identified: Yes No

*If Yes, specify on pages 2-3.

Assurance of Confidentiality: The voluntarily provided information obtained in this surveillance system that would permit identification of any individual or institution is collected with a guarantee that it will be held in strict confidence, will be used only for the purposes stated, and will not otherwise be disclosed or released without the consent of the individual, or the institution in accordance with Sections 304, 306 and 308(d) of the Public Health Service Act (42 USC 242b, 242k, and 242m(d)).

Public reporting burden of this collection of information is estimated to average 32 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC, Reports Clearance Officer, 1600 Clifton Rd., MS D-74, Atlanta, GA 30333, ATTN: PRA (0920-0666).

CDC 57.120 (Front) Rev 4, v6.6

Surgical Site Infection (SSI)

Page 2 of 4

Pathogen #

Gram-positive Organisms


_______


Staphylococcus coagulase-negative


VANC

S I R N

(specify): ________________________


_______


Enterococcus spp.( specify):


AMP

S I R N


CIPRO/LEVO/MOXI

S I R N


DAPTO

S NS N


DOXY/MINO

S I R N


GENTHL§

S R N


LNZ

S I R N

___________


STREPHL§

S R N



TETRA

S I R N



TIG

S NS N



VANC

S I R N



_______



Enterococcus faecium


AMP

S I R N


CIPRO/LEVO/MOXI

S I R N


DAPTO

S NS N


DOXY/MINO

S I R N


GENTHL§

S R N


LNZ

S I R N


QUIDAL

S I R N



STREPHL§

S R N



TETRA

S I R N



TIG

S NS N



VANC

S I R N



_______


Staphylococcus aureus


CHLOR

S I R N


CIPRO/LEVO/MOXI

S I R N


CLIND

S I R N


DAPTO

S NS N


DOXY/MINO

S I R N


ERYTH

S I R N


GENT

S I R N



LNZ

S R N



OX/CEFOX/METH

S I R N


QUIDAL

S I R N


RIF

S I R N


TETRA

S I R N


TIG

S NS N


TMZ

S I R N


VANC

S I R N

Pathogen #

Gram-negative Organisms


_______


Acinetobacter spp. (specify):


AMK

S I R N


AMPSUL

S I R N


AZT

S I R N


CEFEP

S I R N


CEFTAZ

S I R N


CIPRO/LEVO

S I R N


COL/PB

S I R N

____________


GENT

S I R N


IMI

S I R N



MERO/DORI

S I R N


PIP/PIPTAZ

S I R N


TETRA/DOXY/MINO

S I R N




TMZ

S I R N


TOBRA

S I R N



_______


Escherichia coli


AMK

S I R N


AMP

S I R N


AMPSUL/AMXCLV

S I R N


AZT

S I R N


CEFAZ

S I R N


CEFEP

S I R N


CEFOT/CEFTRX

S I R N



CEFTAZ

S I R N


CEFUR

S I R N


CEFOX/CETET

S I R N


CHLOR

S I R N


CIPRO/LEVO/MOXI

S I R N


COL/PB

S I R N



ERTA

S I R N


GENT

S I R N


IMI

S I R N


MERO/DORI

S I R N


PIPTAZ

S I R N


TETRA/DOXY/MINO

S I R N




TIG

S I R N


TMZ

S I R N


TOBRA

S I R N



_______


Enterobacter spp. (specify):


AMK

S I R N


AMP

S I R N


AMPSUL/AMXCLV

S I R N


AZT

S I R N


CEFAZ

S I R N


CEFEP

S I R N


CEFOT/CEFTRX

S I R N

____________


CEFTAZ

S I R N


CEFUR

S I R N


CEFOX/CETET

S I R N


CHLOR

S I R N


CIPRO/LEVO/MOXI

S I R N


COL/PB

S I R N



ERTA

S I R N


GENT

S I R N


IMI

S I R N


MERO/DORI

S I R N


PIPTAZ

S I R N


TETRA/DOXY/MINO

S I R N




TIG

S I R N


TMZ

S I R N


TOBRA

S I R N



_______


Klebsiella spp. (specify):


AMK

S I R N


AMP

S I R N


AMPSUL/AMXCLV

S I R N


AZT

S I R N


CEFAZ

S I R N


CEFEP

S I R N


CEFOT/CEFTRX

S I R N

____________


CEFTAZ

S I R N


CEFUR

S I R N


CEFOX/CETET

S I R N


CHLOR

S I R N


CIPRO/LEVO/MOXI

S I R N


COL/PB

S I R N



ERTA

S I R N


GENT

S I R N


IMI

S I R N


MERO/DORI

S I R N


PIPTAZ

S I R N


TETRA/DOXY/MINO

S I R N



TIG

S I R N


TMZ

S I R N


TOBRA

S I R N


Surgical Site Infection (SSI)

Page 3 of 4

Pathogen #

Gram-negative Organisms (continued)


_______


Serratia marcescens


AMK

S I R N


AMP

S I R N


AMPSUL/AMXCLV

S I R N


AZT

S I R N


CEFAZ

S I R N


CEFEP

S I R N


CEFOT/CEFTRX

S I R N



CEFTAZ

S I R N


CEFUR

S I R N


CEFOX/CETET

S I R N


CHLOR

S I R N


CIPRO/LEVO/MOXI

S I R N


COL/PB

S I R N



ERTA

S I R N


GENT

S I R N


IMI

S I R N


MERO/DORI

S I R N


PIPTAZ

S I R N


TETRA/DOXY/MINO

S I R N




TIG

S I R N


TMZ

S I R N


TOBRA

S I R N



_______


Pseudomonas aeruginosa


AMK

S I R N


AZT

S I R N


CEFEP

S I R N


CEFTAZ

S I R N


CIPRO/LEVO

S I R N


COL/PB

S I R N


GENT

S I R N



IMI

S I R N



MERO/DORI

S I R N


PIP/PIPTAZ

S I R N


TOBRA

S I R N


_______


Stenotrophomonas maltophilia


LEVO

S I R N


TETRA/MINO

S I R N


TICLAV

S I R N


TMZ

S I R N

Pathogen #

Fungal Organisms

_______

Candida spp. (specify): ____________


ANID

S I R N

CASPO

S NS N

FLUCO

S S-DD R N

FLUCY

S I R N

ITRA

S S-DD R N

MICA

S NS N

VORI

S S-DD R N

Pathogen #

Other Organisms

_______

Organism 1 (specify)

____________


_______Drug 1

S I R N

_______ Drug 2

S I R N

______

Drug 3

S I R N

_______ Drug 4

S I R N

_______Drug 5

S I R N

______ Drug 6

S I R N

______ Drug 7

S I R N

______ Drug 8

S I R N

______ Drug 9

S I R N

_______

Organism 1 (specify)

____________


_______Drug 1

S I R N

_______ Drug 2

S I R N

______

Drug 3

S I R N

_______ Drug 4

S I R N

_______Drug 5

S I R N

______ Drug 6

S I R N

______ Drug 7

S I R N

______ Drug 8

S I R N

______ Drug 9

S I R N

_______

Organism 1 (specify)

____________


_______Drug 1

S I R N

_______ Drug 2

S I R N

______

Drug 3

S I R N

_______ Drug 4

S I R N

_______Drug 5

S I R N

______ Drug 6

S I R N

______ Drug 7

S I R N

______ Drug 8

S I R N

______ Drug 9

S I R N


Result Codes

S = Susceptible I = Intermediate R = Resistant NS = Non-susceptible S-DD = Susceptible-dose dependent N = Not tested

§ GENTHL and STREPHL results: S = Susceptible/Synergistic and R = Resistant/Not Synergistic


Drug Codes:





AMK = amikacin

CEFTRX = ceftriaxone

ERYTH = erythromycin

MICA = micafungin

STREPHL = streptomycin –

high level test

AMP = ampicillin

CEFUR= cefuroxime

FLUCO = fluconazole

MINO = minocycline

TETRA = tetracycline

AMPSUL = ampicillin/sulbactam

CETET= cefotetan

FLUCY = flucytosine

MOXI = moxifloxacin

TICLAV = ticarcillin/clavulanic acid

AMXCLV = amoxicillin/clavulanic acid

CHLOR= chloramphenicol

GENT = gentamicin

OX = oxacillin

TIG = tigecycline

ANID = anidulafungin

CIPRO = ciprofloxacin

GENTHL = gentamicin –high level test

PB = polymyxin B

TMZ = trimethoprim/sulfamethoxazole

AZT = aztreonam

CLIND = clindamycin

IMI = imipenem

PIP = piperacillin

TOBRA = tobramycin

CASPO = caspofungin

COL = colistin

ITRA = itraconazole

PIPTAZ = piperacillin/tazobactam

VANC = vancomycin

CEFAZ= cefazolin

DAPTO = daptomycin

LEVO = levofloxacin

QUIDAL = quinupristin/dalfopristin

VORI = voriconazole

CEFEP = cefepime

DORI = doripenem

LNZ = linezolid

RIF = rifampin


CEFOT = cefotaxime

DOXY = doxycycline

MERO = meropenem



CEFOX= cefoxitin

ERTA = ertapenem

METH = methicillin



CEFTAZ = ceftazidime






Surgical Site Infection (SSI)

Page 4 of 4

Custom Fields

Label

Label

______________________

____/____/____

_______________________

____/____/_____

_______________________

_____________

_______________________

______________

_______________________

_____________

_______________________

______________

_________________________

______________

_______________________

______________

_________________________

______________

_______________________

______________

_________________________

______________

_______________________

______________

_________________________

______________

_______________________

______________


Comments
















































File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorAmy Schneider
File Modified0000-00-00
File Created2021-01-30

© 2024 OMB.report | Privacy Policy